January 30, 2026

Rotterdam Summit signals momentum in sustainable fuel investment

Investors join global transport leaders in Rotterdam to assess how policy, technology and capital are aligning to scale sustainable fuels...

Battery storage is becoming core energy infrastructure

BESS gives investors access to flexible infrastructure that supports modern energy systems and the shift to renewables...

Social media algorithms on trial as legal and operational risks mount

A California court case targeting social media algorithms signals rising legal risk for platforms built on engagement, with broader implications for tech investors...

Triton’s electric shower design reduces service risk

Triton designs around predictable failure to keep service demand controlled and customer confidence high...

Meridianbet secures strategic sports branding deal through 2030

Golden Matrix’s Meridianbet renews title sponsorship of EuroLeague club BC Crvena Zvezda through 2030, securing long-term brand visibility across European sports markets...

Pharma teams gain early insight into message effectiveness

Talking Medicines gives pharma teams early insight into which messages resonate with healthcare professionals...

Private equity strategy targets long-term institutional allocations

Private equity exposure through manager stakes offers institutional portfolios a mix of long-term growth and recurring income...

Delay damages patients, and the system pays for it

In joint surgery, delays don’t just postpone care, they increase risk, reduce recovery and raise long-term cost...

Surge in gold and silver points to rising investor caution

Gold and silver gains suggest investors are shifting to safer ground amid rising political and market risks...

Autolus Therapeutics (AUTL) Stock Analysis: A Biotech Gem with a 550% Upside Potential

For investors with a penchant for high-risk, high-reward scenarios, Autolus Therapeutics plc (NASDAQ: AUTL) presents a compelling case. A clinical-stage biopharmaceutical company based in the United Kingdom, Autolus is pioneering..

AtaiBeckley Inc. (ATAI) Stock Analysis: A 219.60% Upside Potential in Innovative Mental Health Treatments

AtaiBeckley Inc. (NASDAQ: ATAI) is garnering significant attention in the biotechnology sector, particularly due to its focus on pioneering treatments for mental health disorders. With an impressive 219.60% potential upside..

Standard BioTools Inc. (LAB) Stock Analysis: Navigating Challenges with a 9.93% Potential Upside

Standard BioTools Inc. (NASDAQ: LAB), a key player in the healthcare sector focusing on medical devices, is navigating a challenging landscape with its innovative proteomics and genomics solutions. The company,..

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a Potential 93.72% Upside

AngioDynamics, Inc. (NASDAQ: ANGO) has emerged as a noteworthy player in the medical technology sector, captivating investor interest with its expansive portfolio of innovative medical devices designed for the treatment..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Promising Biotech with Nearly 95% Upside Potential

Rapport Therapeutics, Inc. (NASDAQ: RAPP), a clinical-stage biopharmaceutical company specializing in central nervous system (CNS) disorders, is garnering significant attention in the investment community. With a market capitalization of $1.27..

MBX Biosciences, Inc. (MBX) Stock Analysis: A Biotech Bet with 65.85% Upside Potential

MBX Biosciences, Inc. (MBX) is rapidly gaining attention within the biotech investment community. With a current market capitalization of $1.65 billion, MBX stands as a formidable player in the healthcare..

Verastem, Inc. (VSTM): Investor Outlook with a Potential Upside of 151.56%

Verastem, Inc. (NASDAQ: VSTM), a rising star in the biotechnology sector, is capturing the attention of savvy investors seeking significant growth opportunities. Specializing in the development and commercialization of cancer..

Oruka Therapeutics, Inc. (ORKA) Stock Report: Biotechnology Pioneer Poised for 57.87% Upside

In the dynamic world of biotechnology, Oruka Therapeutics, Inc. (NASDAQ: ORKA) is carving a niche with its innovative approach to tackling inflammatory and immunological conditions. With a market capitalization of..

Prothena Corporation plc (PRTA) Stock Analysis: Exploring a Potential 124% Upside in Biotech Innovations

Prothena Corporation plc (NASDAQ: PRTA) is a name that has been gaining traction in the biotechnology sector, primarily due to its promising pipeline and strategic collaborations. Based in Dublin, Ireland,..

Bioventus Inc. (BVS) Stock Analysis: Unveiling a Potential 91.82% Upside in the Medical Device Sector

Bioventus Inc. (NASDAQ: BVS), a key player in the healthcare sector with a focus on medical devices, offers an intriguing prospect for investors seeking growth opportunities. Based in Durham, North..

PureTech Health plc (PRTC) Investor Outlook: Unveiling a 542.70% Revenue Growth in the Biotech Arena

In the dynamic landscape of biotechnology, PureTech Health plc (PRTC) is emerging as a noteworthy player, making significant strides in the healthcare sector. Based in Boston, Massachusetts, PureTech Health is..

Search

Funds

January 30, 2026

Rotterdam Summit signals momentum in sustainable fuel investment

Investors join global transport leaders in Rotterdam to assess how policy, technology and capital are aligning to scale sustainable fuels...

Battery storage is becoming core energy infrastructure

BESS gives investors access to flexible infrastructure that supports modern energy systems and the shift to renewables...

Social media algorithms on trial as legal and operational risks mount

A California court case targeting social media algorithms signals rising legal risk for platforms built on engagement, with broader implications for tech investors...

Triton’s electric shower design reduces service risk

Triton designs around predictable failure to keep service demand controlled and customer confidence high...

Meridianbet secures strategic sports branding deal through 2030

Golden Matrix’s Meridianbet renews title sponsorship of EuroLeague club BC Crvena Zvezda through 2030, securing long-term brand visibility across European sports markets...

Pharma teams gain early insight into message effectiveness

Talking Medicines gives pharma teams early insight into which messages resonate with healthcare professionals...

Private equity strategy targets long-term institutional allocations

Private equity exposure through manager stakes offers institutional portfolios a mix of long-term growth and recurring income...

Delay damages patients, and the system pays for it

In joint surgery, delays don’t just postpone care, they increase risk, reduce recovery and raise long-term cost...

Surge in gold and silver points to rising investor caution

Gold and silver gains suggest investors are shifting to safer ground amid rising political and market risks...
Search

Funds

January 30, 2026

FTSE 100

Funds